Immunohistochemical detection of p53 and MDM2 expressions in liposarcoma with World health organization classification

dc.contributor.authorArıcı, Akgül
dc.contributor.authorÖzgür, Tümay
dc.contributor.buuauthorUǧraş, Nesrin
dc.contributor.buuauthorYalçınkaya, Ulviye
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.tr_TR
dc.contributor.researcheridAAH-8924-2021tr_TR
dc.contributor.researcheridAAH-2716-2021tr_TR
dc.contributor.scopusid55386535600tr_TR
dc.contributor.scopusid6508300295tr_TR
dc.date.accessioned2023-05-12T11:27:30Z
dc.date.available2023-05-12T11:27:30Z
dc.date.issued2013
dc.description.abstractBackground: Liposarcomas are among the most common soft tissue sarcomas in adulthood. Aim: The purpose of the study is to perform a histopathologic typing according to World Health Organization (WHO) classification of cases diagnosed with liposarcoma and to examine the difference of p53 and MDM2 expressions. Materials and Methods: The haematoxylin-eosin stained sections of 48 subjects enrolled in the study have been evaluated on the basis of the WHO classification for liposarcoma and sections stained using p53 and MDM2. Statistical Analysis Used: Chi-Square test was applied. Results: 20 subjects were diagnosed with well-differentiated liposarcoma (WLS), 16 myxoid liposarcoma (ML), 7 pleomorphic liposarcoma (PL), and 5 de-differentiated liposarcoma (DLS). The number of cases stained positive with MDM2 and p53 were positive correlated in all subjects (P = 0.02). p53 and MDM2 positivity increased in high grade tumors (P = 0.01). Conclusion: p53 and MDM2 immuno-reactivity was found to be potentially useful in liposarcoma diagnosis but a definitive implication would be rather unhealthy due to the small number of cases in our study.en_US
dc.identifier.citationArıcı, A. (2013). “Immunohistochemical detection of p53 and MDM2 expressions in liposarcoma with World health organization classification”. Indian Journal of Cancer, 50(3), 164-169.en_US
dc.identifier.endpage169tr_TR
dc.identifier.issn0019-509X
dc.identifier.issn1998-4774
dc.identifier.issue3tr_TR
dc.identifier.pubmed24061453tr_TR
dc.identifier.scopus2-s2.0-84885404443tr_TR
dc.identifier.startpage164tr_TR
dc.identifier.urihttps://doi.org/10.4103/0019-509X.118717
dc.identifier.urihttp://hdl.handle.net/11452/32647
dc.identifier.volume50tr_TR
dc.identifier.wos000339909300002tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalIndian Journal of Canceren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOncologyen_US
dc.subjectLiposarcomaen_US
dc.subjectMDM2en_US
dc.subjectp53en_US
dc.subjectWorld health organization classificationen_US
dc.subjectGene amplificationen_US
dc.subjectCell liposarcomaen_US
dc.subjectTumorsen_US
dc.subjectPrognosisen_US
dc.subjectPatternsen_US
dc.subject.emtreeEosinen_US
dc.subject.emtreeHematoxylinen_US
dc.subject.emtreeProtein MDM2en_US
dc.subject.emtreeProtein p53en_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeCancer classificationen_US
dc.subject.emtreeCancer localizationen_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeHistopathologyen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHuman tissueen_US
dc.subject.emtreeImmunohistochemistryen_US
dc.subject.emtreeImmunoreactivityen_US
dc.subject.emtreeLiposarcomaen_US
dc.subject.emtreeMyxosarcomaen_US
dc.subject.emtreePleomorphic liposarcomaen_US
dc.subject.emtreeProtein expressionen_US
dc.subject.emtreeWell differentiated liposarcomaen_US
dc.subject.emtreeWorld health organizationen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshImmunohistochemistryen_US
dc.subject.meshLiposarcomaen_US
dc.subject.meshMaleen_US
dc.subject.meshProto-oncogene proteins c-mdm2en_US
dc.subject.meshSoft tissue neoplasmsen_US
dc.subject.meshTumor markers, biologicalen_US
dc.subject.meshTumor suppressor protein p53en_US
dc.subject.meshWorld health organizationen_US
dc.subject.scopusLiposarcoma; Spermatic Cord; Case Reporten_US
dc.subject.wosOncologyen_US
dc.titleImmunohistochemical detection of p53 and MDM2 expressions in liposarcoma with World health organization classificationen_US
dc.typeArticle
dc.wos.quartileQ4en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: